ArticleTranslational cancer research2024

Non-targeted metabolomics analysis of indoleamine 2,3-dioxygenase inhibitor treatment in a mouse model of early-stage lung adenocarcinoma.

Meixiang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.